- Home
- NMRA vs JUNS Comparison
NMRA vs JUNS Comparison
Compare NMRA & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- JUNS
- Stock Information
- Founded
- NMRA 2019
- JUNS 2015
- Country
- NMRA United States
- JUNS United States
- Employees
- NMRA N/A
- JUNS N/A
- Industry
- NMRA
- JUNS
- Sector
- NMRA
- JUNS
- Exchange
- NMRA Nasdaq
- JUNS NYSE
- Market Cap
- NMRA 121.0M
- JUNS 20.5M
- IPO Year
- NMRA 2023
- JUNS 2024
- Fundamental
- Price
- NMRA $1.03
- JUNS $1.48
- Analyst Decision
- NMRA Buy
- JUNS
- Analyst Count
- NMRA 8
- JUNS 0
- Target Price
- NMRA $9.29
- JUNS N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- JUNS 1.0M
- Earning Date
- NMRA 08-05-2025
- JUNS 08-11-2025
- Dividend Yield
- NMRA N/A
- JUNS N/A
- EPS Growth
- NMRA N/A
- JUNS N/A
- EPS
- NMRA N/A
- JUNS N/A
- Revenue
- NMRA N/A
- JUNS N/A
- Revenue This Year
- NMRA N/A
- JUNS N/A
- Revenue Next Year
- NMRA N/A
- JUNS N/A
- P/E Ratio
- NMRA N/A
- JUNS N/A
- Revenue Growth
- NMRA N/A
- JUNS N/A
- 52 Week Low
- NMRA $0.61
- JUNS $0.51
- 52 Week High
- NMRA $17.19
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- NMRA 67.61
- JUNS N/A
- Support Level
- NMRA $0.72
- JUNS N/A
- Resistance Level
- NMRA $0.85
- JUNS N/A
- Average True Range (ATR)
- NMRA 0.08
- JUNS 0.00
- MACD
- NMRA 0.02
- JUNS 0.00
- Stochastic Oscillator
- NMRA 100.00
- JUNS 0.00
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.